<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.nutritionandmetabolism.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Nutrition &amp; Metabolism - Most accessed articles</title>
        <link>http://www.nutritionandmetabolism.com</link>
        <description>The most accessed research articles published by Nutrition &amp; Metabolism</description>
        <dc:date>2010-03-02T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/2/1/5" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/2/1/25" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/7/1/7" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/1/1/2" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/7/1/17" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/1/1/5" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/7/1/12" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/5/1/9" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/7/1/10" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/5/1/1" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/2/1/5">
        <title>Fructose, insulin resistance, and metabolic dyslipidemia</title>
        <description>Obesity and type 2 diabetes are occurring at epidemic rates in the United States and many parts of the world. The &quot;obesity epidemic&quot; appears to have emerged largely from changes in our diet and reduced physical activity. An important but not well-appreciated dietary change has been the substantial increase in the amount of dietary fructose consumption from high intake of sucrose and high fructose corn syrup, a common sweetener used in the food industry. A high flux of fructose to the liver, the main organ capable of metabolizing this simple carbohydrate, perturbs glucose metabolism and glucose uptake pathways, and leads to a significantly enhanced rate of de novo lipogenesis and triglyceride (TG) synthesis, driven by the high flux of glycerol and acyl portions of TG molecules from fructose catabolism. These metabolic disturbances appear to underlie the induction of insulin resistance commonly observed with high fructose feeding in both humans and animal models. Fructose-induced insulin resistant states are commonly characterized by a profound metabolic dyslipidemia, which appears to result from hepatic and intestinal overproduction of atherogenic lipoprotein particles. Thus, emerging evidence from recent epidemiological and biochemical studies clearly suggests that the high dietary intake of fructose has rapidly become an important causative factor in the development of the metabolic syndrome. There is an urgent need for increased public awareness of the risks associated with high fructose consumption and greater efforts should be made to curb the supplementation of packaged foods with high fructose additives. The present review will discuss the trends in fructose consumption, the metabolic consequences of increased fructose intake, and the molecular mechanisms leading to fructose-induced lipogenesis, insulin resistance and metabolic dyslipidemia.</description>
        <link>http://www.nutritionandmetabolism.com/content/2/1/5</link>
                <dc:creator>Heather Basciano</dc:creator>
                <dc:creator>Lisa Federico</dc:creator>
                <dc:creator>Khosrow Adeli</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2005, 2:5</dc:source>
        <dc:date>2005-02-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-2-5</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2005-02-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/2/1/25">
        <title>Dietary protein intake and renal function</title>
        <description>Recent trends in weight loss diets have led to a substantial increase in protein intake by individuals. As a result, the safety of habitually consuming dietary protein in excess of recommended intakes has been questioned. In particular, there is concern that high protein intake may promote renal damage by chronically increasing glomerular pressure and hyperfiltration. There is, however, a serious question as to whether there is significant evidence to support this relationship in healthy individuals. In fact, some studies suggest that hyperfiltration, the purported mechanism for renal damage, is a normal adaptative mechanism that occurs in response to several physiological conditions. This paper reviews the available evidence that increased dietary protein intake is a health concern in terms of the potential to initiate or promote renal disease. While protein restriction may be appropriate for treatment of existing kidney disease, we find no significant evidence for a detrimental effect of high protein intakes on kidney function in healthy persons after centuries of a high protein Western diet.</description>
        <link>http://www.nutritionandmetabolism.com/content/2/1/25</link>
                <dc:creator>William Martin</dc:creator>
                <dc:creator>Lawrence Armstrong</dc:creator>
                <dc:creator>Nancy Rodriguez</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2005, 2:25</dc:source>
        <dc:date>2005-09-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-2-25</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2005-09-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/7/1/7">
        <title>Cancer as a metabolic disease</title>
        <description>Emerging evidence indicates that impaired cellular energy metabolism is the defining characteristic of nearly all cancers regardless of cellular or tissue origin.  In contrast to normal cells, which derive most of their usable energy from oxidative phosphorylation, most cancer cells become heavily dependent on substrate level phosphorylation to meet energy demands.  Evidence is reviewed supporting a general hypothesis that genomic instability and essentially all hallmarks of cancer, including aerobic glycolysis (Warburg effect), can be linked to impaired mitochondrial function and energy metabolism.  A view of cancer as primarily a metabolic disease will impact approaches to cancer management and prevention.</description>
        <link>http://www.nutritionandmetabolism.com/content/7/1/7</link>
                <dc:creator>Thomas Seyfried</dc:creator>
                <dc:creator>Laura Shelton</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2010, 7:7</dc:source>
        <dc:date>2010-01-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-7-7</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2010-01-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/1/1/2">
        <title>Ketogenic diets and physical performance</title>
        <description>Impaired physical performance is a common but not obligate result of a low carbohydrate diet. Lessons from traditional Inuit culture indicate that time for adaptation, optimized sodium and potassium nutriture, and constraint of protein to 15&#8211;25 % of daily energy expenditure allow unimpaired endurance performance despite nutritional ketosis.</description>
        <link>http://www.nutritionandmetabolism.com/content/1/1/2</link>
                <dc:creator>Stephen Phinney</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2004, 1:2</dc:source>
        <dc:date>2004-08-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-1-2</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2004-08-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/7/1/17">
        <title>Resistance training in overweight women on a ketogenic diet conserved lean body mass while reducing body fat </title>
        <description>Background:
The aim of the present study was to compare the effects of 10 weeks resistance training in combination with either a regular diet (Ex) or a low carbohydrate, ketogenic diet (Lc+Ex) in overweight women on body weight and body composition.
Methods:
18 untrained women between 20 and 40 years with BMI [greater than or equal to] 25 kg*m-2 were randomly assigned into the Ex or Lc+Ex group. Both groups performed 60-100 min of varied resistance exercise twice weekly. Dietary estimates were based on two 4-day weighed records. Body composition was estimated using Dual Energy X-ray Absorptiometry. Fasting blood samples were analyzed for total-, HDL- and LDL-cholesterol, triacylglycerols, and glucose.
Results:
16 subjects were included in the analyses. Percentage of energy (En%) from carbohydrates, fat and protein was 6, 66, and 22 respectively in the (Lc+Ex) group and 41, 34, 17 in the Ex group. Mean weight change (pre-post) was -5.6 +/- 2.6 kg in Lc+Ex; (p&lt;0.001) and 0.8 +/- 1.5 kg in Ex; (p=0.175). The Lc+Ex group lost 5.6 +/- 2.9 kg of fat mass (p=0.001) with no significant change in lean body mass (LBM), while the Ex group gained 1.6 +/- 1.8kg of LBM (p=0.045) with no significant change in fat mass (p=0.059). Fasting blood lipids and blood glucose were not significantly affected by the interventions.
Conclusion:
Resistance exercise in combination with a ketogenic diet may reduce body fat without significantly changing LBM, while resistance exercise on a regular diet may increase LBM without significantly affecting fat mass. Fasting blood lipids do not seem to be negatively influenced by the combination of resistance exercise and a low carbohydrate diet.</description>
        <link>http://www.nutritionandmetabolism.com/content/7/1/17</link>
                <dc:creator>Pal Jabekk</dc:creator>
                <dc:creator>Ingvild Moe</dc:creator>
                <dc:creator>Helge Meen</dc:creator>
                <dc:creator>Sissel Tomten</dc:creator>
                <dc:creator>Arne Hostmark</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2010, 7:17</dc:source>
        <dc:date>2010-03-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-7-17</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2010-03-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/1/1/5">
        <title>Diet induced thermogenesis</title>
        <description>ObjectiveDaily energy expenditure consists of three components: basal metabolic rate, diet-induced thermogenesis and the energy cost of physical activity. Here, data on diet-induced thermogenesis are reviewed in relation to measuring conditions and characteristics of the diet.
Methods:
Measuring conditions include nutritional status of the subject, physical activity and duration of the observation. Diet characteristics are energy content and macronutrient composition.
Results:
Most studies measure diet-induced thermogenesis as the increase in energy expenditure above basal metabolic rate. Generally, the hierarchy in macronutrient oxidation in the postprandial state is reflected similarly in diet-induced thermogenesis, with the sequence alcohol, protein, carbohydrate, and fat. A mixed diet consumed at energy balance results in a diet induced energy expenditure of 5 to 15 % of daily energy expenditure. Values are higher at a relatively high protein and alcohol consumption and lower at a high fat consumption. Protein induced thermogenesis has an important effect on satiety.In conclusion, the main determinants of diet-induced thermogenesis are the energy content and the protein- and alcohol fraction of the diet. Protein plays a key role in body weight regulation through satiety related to diet-induced thermogenesis.</description>
        <link>http://www.nutritionandmetabolism.com/content/1/1/5</link>
                <dc:creator>Klaas Westerterp</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2004, 1:5</dc:source>
        <dc:date>2004-08-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-1-5</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2004-08-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/7/1/12">
        <title>Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study</title>
        <description>Background:
Drinking coffee has been linked to reduced calcium conservation, but it is less clear whether it leads to sustained bone mineral loss and if individual predisposition for caffeine metabolism might be important in this context. Therefore, the relation between consumption of coffee and bone mineral density (BMD) at the proximal femur in men and women was studied, taking into account, for the first time, genotypes for cytochrome P450 1A2 (CYP1A2) associated with metabolism of caffeine.
Methods:
Dietary intakes of 359 men and 358 women (aged 72 years), participants of the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS), were assessed by a 7-day food diary. Two years later, BMD for total proximal femur, femoral neck and trochanteric regions of the proximal femur were measured by Dual-energy X-ray absorptiometry (DXA). Genotypes of CYP1A2 were determined. Adjusted means of BMD for each category of coffee consumption were calculated.
Results:
Men consuming 4 cups of coffee or more per day had 4% lower BMD at the proximal femur (p=0.04) compared with low or non-consumers of coffee. This difference was not observed in women. In high consumers of coffee, those with rapid metabolism of caffeine (C/C genotype) had lower BMD at the femoral neck (p= 0.01) and at the trochanter (p= 0.03)  than slow metabolizers (T/T and C/T genotypes). Calcium intake did not modify the relation between coffee and BMD.
Conclusion:
High consumption of coffee seems to contribute to a reduction in BMD of the proximal femur in elderly men, but not in women. BMD was lower in high consumers of coffee with rapid metabolism of caffeine, suggesting that rapid metabolizers of caffeine may constitute a risk group for bone loss induced by coffee.</description>
        <link>http://www.nutritionandmetabolism.com/content/7/1/12</link>
                <dc:creator>Helena Hallstrom</dc:creator>
                <dc:creator>Hakan Melhus</dc:creator>
                <dc:creator>Anders Glynn</dc:creator>
                <dc:creator>Lars Lind</dc:creator>
                <dc:creator>Ann-Christine Syvanen</dc:creator>
                <dc:creator>Karl Michaelsson</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2010, 7:12</dc:source>
        <dc:date>2010-02-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-7-12</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2010-02-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/5/1/9">
        <title>Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal</title>
        <description>Current nutritional approaches to metabolic syndrome and type 2 diabetes generally rely on reductions in dietary fat. The success of such approaches has been limited and therapy more generally relies on pharmacology. The argument is made that a re-evaluation of the role of carbohydrate restriction, the historical and intuitive approach to the problem, may provide an alternative and possibly superior dietary strategy. The rationale is that carbohydrate restriction improves glycemic control and reduces insulin fluctuations which are primary targets. Experiments are summarized showing that carbohydrate-restricted diets are at least as effective for weight loss as low-fat diets and that substitution of fat for carbohydrate is generally beneficial for risk of cardiovascular disease. These beneficial effects of carbohydrate restriction do not require weight loss. Finally, the point is reiterated that carbohydrate restriction improves all of the features of metabolic syndrome.</description>
        <link>http://www.nutritionandmetabolism.com/content/5/1/9</link>
                <dc:creator>Anthony Accurso</dc:creator>
                <dc:creator>Richard Bernstein</dc:creator>
                <dc:creator>Annika Dahlqvist</dc:creator>
                <dc:creator>Boris Draznin</dc:creator>
                <dc:creator>Richard Feinman</dc:creator>
                <dc:creator>Eugene Fine</dc:creator>
                <dc:creator>Amy Gleed</dc:creator>
                <dc:creator>David Jacobs</dc:creator>
                <dc:creator>Gabriel Larson</dc:creator>
                <dc:creator>Robert Lustig</dc:creator>
                <dc:creator>Anssi Manninen</dc:creator>
                <dc:creator>Samy McFarlane</dc:creator>
                <dc:creator>Katharine Morrison</dc:creator>
                <dc:creator>Jorgen Nielsen</dc:creator>
                <dc:creator>Uffe Ravnskov</dc:creator>
                <dc:creator>Karl Roth</dc:creator>
                <dc:creator>Ricardo Silvestre</dc:creator>
                <dc:creator>James Sowers</dc:creator>
                <dc:creator>Ralph Sundberg</dc:creator>
                <dc:creator>Jeff Volek</dc:creator>
                <dc:creator>Eric Westman</dc:creator>
                <dc:creator>Richard Wood</dc:creator>
                <dc:creator>Jay Wortman</dc:creator>
                <dc:creator>Mary Vernon</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2008, 5:9</dc:source>
        <dc:date>2008-04-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-5-9</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2008-04-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/7/1/10">
        <title>Carbohydrate intake and cardiometabolic risk factors in high BMI African American children  </title>
        <description>The aim of this study was to evaluate the relationship between intakes of subgroups of energy-providing carbohydrate, and markers of cardiometabolic risk factors in high BMI African American (AA) children.A cross sectional analysis was performed on data from a sample of 9-11 year old children (n = 95) with BMI greater than the 85th percentile. Fasting hematological and biochemical values for selected markers of cardiometabolic risk factors were related to intakes of carbohydrates and sugars.After adjusting for gender, pubertal stage and waist circumference, multivariate regression analysis showed that higher intakes of carbohydrate (with fat and protein held constant) were associated with higher plasma concentrations of triglycerides (TG), VLDL-C, IDL-C, and worse insulin resistance (homeostasis model assessment of insulin resistance, HOMA-IR). After dividing carbohydrate into non-sugar versus sugar fractions, sugars were significantly related to higher TG, VLDL-C, IDL-C, lower adipocyte fatty acid insulin sensitivity (ISI-FFA), and was closely associated with increased HOMA-IR. Similar trends were observed for sugars classified as added sugars, and for sugars included in beverages. Further dividing sugar according to the food group from which it was consumed showed that consuming more sugar from the candy/soda food group was highly significantly associated with increased TG, VLDL-C, IDL-C and closely associated with increased HOMA-IR. Sugars consumed in all fruit-containing foods were significantly associated with lower ISI-FFA. Sugars consumed as fruit beverages was significantly associated with VLDL-C, IDL-C and ISI-FFA whereas sugars consumed as fresh, dried and preserved fruits did not show significant associations with these markers.Sugars consumed from in all dairy foods were significantly associated with higher TG, VLDL-C and IDL-C, and with significantly lower HDL-C and ISI-FFA. These effects were associated with sugars consumed in sweetened dairy products, but not with sugars consumed in unsweetened dairy products. This analysis suggests that increases in carbohydrate energy, especially in the form of sugar, may be detrimental to cardiometabolic health in high BMI children.</description>
        <link>http://www.nutritionandmetabolism.com/content/7/1/10</link>
                <dc:creator>Sushma Sharma</dc:creator>
                <dc:creator>Lindsay Roberts</dc:creator>
                <dc:creator>Robert Lustig</dc:creator>
                <dc:creator>Sharon Fleming</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2010, 7:10</dc:source>
        <dc:date>2010-02-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-7-10</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2010-02-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/5/1/1">
        <title>Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: A review</title>
        <description>The leucine metabolite beta-hydroxy-beta-methylbutyrate (HMB) has been extensively used as an ergogenic aid; particularly among bodybuilders and strength/power athletes, who use it to promote exercise performance and skeletal muscle hypertrophy. While numerous studies have supported the efficacy of HMB in exercise and clinical conditions, there have been a number of conflicting results. Therefore, the first purpose of this paper will be to provide an in depth and objective analysis of HMB research. Special care is taken to present critical details of each study in an attempt to both examine the effectiveness of HMB as well as explain possible reasons for conflicting results seen in the literature. Within this analysis, moderator variables such as age, training experience, various states of muscle catabolism, and optimal dosages of HMB are discussed. The validity of dependent measurements, clustering of data, and a conflict of interest bias will also be analyzed. A second purpose of this paper is to provide a comprehensive discussion on possible mechanisms, which HMB may operate through. Currently, the most readily discussed mechanism has been attributed to HMB as a precursor to the rate limiting enzyme to cholesterol synthesis HMG-coenzyme A reductase. However, an increase in research has been directed towards possible proteolytic pathways HMB may operate through. Evidence from cachectic cancer studies suggests that HMB may inhibit the ubiquitin-proteasome proteolytic pathway responsible for the specific degradation of intracellular proteins. HMB may also directly stimulate protein synthesis, through an mTOR dependent mechanism. Finally, special care has been taken to provide future research implications.</description>
        <link>http://www.nutritionandmetabolism.com/content/5/1/1</link>
                <dc:creator>Gabriel Wilson</dc:creator>
                <dc:creator>Jacob Wilson</dc:creator>
                <dc:creator>Anssi Manninen</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2008, 5:1</dc:source>
        <dc:date>2008-01-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-5-1</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2008-01-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
